FindTrial
Sign In

A study on the incidence and clinical characteristics of acute angle-closure glaucoma during the COVID-19 epidemic in theTianjin Medical University Eye Hospital

A study on the incidence and clinical characteristics of acute angle-closure glaucoma during the COVID-19 epidemic in theTianjin Medical University Eye Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068091
Enrollment
Unknown
Registered
2023-02-07
Start date
2023-02-07
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute attack of primary angle closure glaucoma

Interventions

Observation group:NA

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Ocular pain and frontal headache on the side of affected eye (possible accompanying symptoms, such as nausea, vomiting and abdominal cramps); 2. Decreased visual acuity; 3. High IOP, often more than 40mmHg; 4. Ciliary injection, corneal oedema, shallow or flat peripheral anterior chamber.

Exclusion criteria

Exclusion criteria: Secondary angle closure glaucoma, such as lens-induced glaucoma, uveitic glaucoma or glaucoma secondary to surgeries.

Design outcomes

Primary

MeasureTime frame
prevalence rate;—

Secondary

MeasureTime frame
Anterior chamber depth;Ocular axis length;—

Countries

China

Contacts

Public ContactXiaoli Xing

Tianjin Medical University Eye Hospital

2218087865@qq.com+86 22 8642 8803

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026